Peter MD vs SkinnyRx: Men's Health Add-Ons vs Low-Friction GLP-1 Access in 2026

Choose Peter MD if you want GLP-1 access inside a broader men's health clinic. Choose SkinnyRx if you want a simpler medication-specific path for compounded semaglutide or tirzepatide.

Peter MD is the better fit for buyers comparing weight loss treatment with TRT, ED medication, hair loss products, NAD or longevity add-ons, and one-account health optimization. Start with Peter MD if that bundle is the point.

SkinnyRx is the cleaner fit if you already know you want semaglutide or tirzepatide and care more about intake speed, free shipping, month-to-month cancellation, and lower advertised entry pricing than coaching. Start with SkinnyRx, SkinnyRx semaglutide, or SkinnyRx tirzepatide.

Both routes are framed here around compounded GLP-1 access, not guaranteed dispensing of brand-name Wegovy, Ozempic, Zepbound, or Mounjaro. That matters for expectations, evidence, and safety.

Quick comparison

Peter MD: PeptidePub rating 4.0/5, updated June 2026, with a local review read time of 9 min. Best for men who want one-account health optimization. Peter MD lists a GLP-1 subscription at $270/month, marked down from $417, with shipping, supplies, doctor consult, app access, meal plans, exercise plans, unlimited clinician access, cost of medicine included, same price at all doses, no insurance hassle, no waitlist, no hidden fees, fast approval, and cancel-anytime billing. Its official tirzepatide product page lists a 60 mg vial at $647. The broader menu includes TRT, ED medication, hair loss, and longevity care.

SkinnyRx: PeptidePub rating 4.3/5, updated June 2026, with a local review read time of 7 min. Best for people who want medication choice. Official snippets list compounded injectable semaglutide from $149.25/month, sublingual semaglutide from $199/month, semaglutide tablets from $249/month, and compounded injectable tirzepatide from $224.25/month. The local review lists compounded tirzepatide at $299/month. Treat SkinnyRx pricing as format-dependent and promotion-dependent, then verify at checkout.

Pricing and value

Peter MD is usually not the cheapest pure semaglutide route, but the price buys a wider clinic context. Its GLP-1 weight loss plan is $270/month. A separate tirzepatide product page lists Tirzepatide 60mg at $647 and says a doctor appointment is required before medication ships. Another Peter MD tirzepatide page shows a 60mg plan at $315, get started for $149, then $249 per month billed quarterly. That same landing page also displays $628, get started for $149, then $249 per month billed quarterly for a 60mg plan. The clean takeaway: Peter MD tirzepatide pricing is page-dependent, so verify the final checkout terms.

Peter MD also lists TRT from $99 to $149/month, with testosterone cypionate, testosterone gel, nasal gel, and baseline hormone labs included. ED medications run $40 to $80/month. Its local review notes free consultations, free shipping, and a price match guarantee.

SkinnyRx is the lower-friction GLP-1 lane. The official snippets show injectable semaglutide from $149.25/month, sublingual semaglutide from $199/month, tablets from $249/month, and injectable tirzepatide from $224.25/month. The local review lists compounded tirzepatide at $299/month, initial consultation included, free shipping, month-to-month plans, and cancel-anytime billing.

Care model and availability

Peter MD is a bundle clinic. It covers weight loss, TRT, ED, hair loss, finasteride, minoxidil, FollicureRX, NAD+ capsules, and longevity products. The GLP-1 pages emphasize online prescriptions, app or web portal management, easy refills, records access, shipping, supplies, dietician guidance on the tirzepatide page, and ongoing clinician access. The tradeoff is focus: the local review calls it broad rather than deep, with men-focused branding and newer longevity offerings.

SkinnyRx is medication-specific. It connects patients with licensed healthcare providers and 503A-registered compounding pharmacies, but is not a pharmacy itself. The sign-up flow is choose medication, complete an online health assessment, provider review and approval usually in 24 to 48 hours, medication shipped to your door, then message the provider for dose adjustments. Included items are medical evaluation, prescription management, monthly delivery, provider access for dose changes, basic support by messaging, and injection supplies. There is no coaching or lifestyle support, limited provider interaction, and no standard video appointments.

Peter MD GLP-1 subscription is not available in AL, AR, CA, HI, ID, MI, NC, or TX. Peter MD tirzepatide pages list a narrower restriction: not available in AL and ID. SkinnyRx snippets list products as in stock, Rx, FSA/HSA eligible, with microdose options for injectable semaglutide and injectable tirzepatide.

Medication formats and evidence caveats

Peter MD local review lists compounded semaglutide with B12 and compounded tirzepatide. Its official GLP-1 subscription page describes an injectable GLP-1 for at-home use, but does not name the molecule on that page. SkinnyRx supports more separate medication formats: injectable semaglutide, sublingual semaglutide, semaglutide tablets, and injectable tirzepatide.

Do not treat all of those formats as clinically interchangeable. The strongest obesity trial evidence here is for injectable semaglutide and injectable tirzepatide. In STEP 1, once-weekly injectable semaglutide 2.4 mg produced mean body weight change of -14.9% at week 68 versus -2.4% with placebo, an estimated treatment difference of -12.4 percentage points. At least 5% weight loss occurred in 86.4% versus 31.5%, at least 10% in 69.1% versus 12.0%, and at least 15% in 50.5% versus 4.9%. GI-event discontinuation was 4.5% versus 0.8%.

In SURMOUNT-1, injectable tirzepatide produced 16.0%, 21.4%, and 22.5% average weight reductions at 72 weeks for 5 mg, 10 mg, and 15 mg, compared with 2.4% for placebo. At least 5% loss occurred in 89% to 96% versus 28%; at least 15% loss in 50%, 74%, and 78% versus 6.0%; and at least 20% loss in 32%, 55%, and 63% versus 1.3%.

Safety caveats buyers should know

SURMOUNT-1 also shows why side effects need real monitoring. Nausea occurred in 24.6%, 33.3%, and 31.0% of tirzepatide users by dose versus 9.5% on placebo. Diarrhea was 18.7%, 21.2%, and 23.0% versus 7.3%. Constipation was 16.8%, 17.1%, and 11.7% versus 5.8%. Vomiting was 8.3%, 10.7%, and 12.2% versus 1.7%. Adverse-event discontinuation was 4.3%, 7.1%, and 6.2% versus 2.6%. For practical mitigation, see our GLP-1 side effects management guide.

The compounded-drug caveat is separate. The FDA says compounded drugs do not undergo FDA premarket review for safety, quality, or effectiveness. The agency has reported semaglutide dosing errors from patients and providers, often involving multi-dose vials, syringe measurement confusion, units versus milligrams or milliliters, varying concentrations, and patients receiving 5 to 20 times the intended dose. Reported adverse events included nausea, vomiting, abdominal pain, fainting, headache, migraine, dehydration, acute pancreatitis, and gallstones.

The FDA has also noted that some compounders add B12, B6, L-carnitine, or NAD to semaglutide products, and the safety and effectiveness of combining semaglutide with other ingredients has not been established. That caveat is especially relevant when comparing B12 blends or longevity-style add-ons.

Who should choose which

Choose Peter MD if you want a GLP-1 plus men's health add-ons in one account. That means Peter MD makes more sense if TRT, ED medication, hair loss treatment, NAD+ capsules, longevity products, app-based refills, free consultations, free shipping, or a price match guarantee matter more than the lowest advertised semaglutide price. It may not fit if you want women-focused branding, the simplest GLP-1-only checkout, a brand-name GLP-1 path, or a clinic specializing exclusively in weight management.

Choose SkinnyRx if you already know the medication lane you want and prefer a straightforward intake. SkinnyRx is better for shoppers who want separate semaglutide and tirzepatide plans, lower advertised semaglutide entry pricing, month-to-month cancellation, included consultation, free shipping, and basic provider messaging. For more context, compare is SkinnyRx legit, Novi vs SkinnyRx, and Shed vs SkinnyRx.

SkinnyRx may not fit if you want structured lifestyle coaching, routine video visits, lab-heavy clinical oversight, or brand-name GLP-1 prescribing. For market-wide context, use our cheapest semaglutide online, compounded tirzepatide cost, best online weight loss program, and compounded vs brand GLP-1 guides.

FAQ

Which is cheaper, Peter MD or SkinnyRx? SkinnyRx usually advertises lower entry prices for GLP-1-only access: injectable semaglutide from $149.25/month and injectable tirzepatide from $224.25/month in current snippets. Peter MD lists GLP-1 at $270/month and a tirzepatide 60 mg vial at $647, but also shows a $149 get-started tirzepatide offer then $249/month billed quarterly on another page. Verify at checkout.

Is Peter MD better than SkinnyRx? Only if you value the broader men's health setup. Peter MD wins for bundling. SkinnyRx wins for simpler medication-specific plans.

Does either offer brand-name Wegovy or Zepbound? The reviewed PeptidePub pages frame both around compounded GLP-1 access, not guaranteed brand-name dispensing.

Can I get tirzepatide from both? Yes. Peter MD lists tirzepatide products, and SkinnyRx lists compounded injectable tirzepatide.

Are compounded GLP-1s FDA-approved? No. Compounded drugs are not FDA-approved finished products and do not undergo FDA premarket review for safety, quality, or effectiveness. Discuss the specific product, concentration, syringe instructions, and dose escalation plan with a licensed clinician.

Bottom line

Peter MD wins if you want GLP-1 access as part of a broader men's health setup and are willing to pay for that wider menu. SkinnyRx wins if you want a simpler GLP-1 route with medication-specific semaglutide and tirzepatide plans and lower advertised entry pricing. Bundle shoppers should start with Peter MD. Semaglutide shoppers should start with SkinnyRx semaglutide. Tirzepatide shoppers should start with SkinnyRx tirzepatide.